Bioanalytics, Metabolomics & Pharmacokinetics (BMPK) Shared Resource (Formerly PK/PD)

The mission of the Bioanalytics, Metabolomics & Pharmacokinetics (BMPK) Shared Resource is to support clinical research and clinical/pre-clinical drug development at Roswell Park, as well as to provide bioanalytical and consultation services to industry. BMPK provides state-of-the-art analytical scientific data in conjunction with PK studies of cancer therapeutics and preventive agents. In addition, our group advises investigators on PK/PD study design along with sample collection, handling, and dose selection in order to optimize the therapeutic window of oncology drug products.

The BMPK Shared Resource provides comprehensive services from study design consultation and methodology development to sample storage, preparation, assay, and data analysis. The Resource offers a wide variety of analytical assays along with the capabilities to develop and validate new methods. Using cutting edge techniques with LC/MS/MS, UPLC, HPLC, and Atomic Absorption spectrophotometry, BMPK provides highly sensitive measurements for an extensive array of chemotherapeutic agents and metabolites. Please see the attached file below for a recent listing of key contributions the BMPK Shared Resource has provided to Roswell Park and the local research community.


Roswell Park Comprehensive Cancer Center
BMPK Shared Resource
CGP, Room L1-140
Elm and Carlton Streets
Buffalo, New York 14263

Operating Schedule

Monday - Friday, 8 a.m. - 5 p.m.

Core Grant Citation

This shared resource is funded by NCI P30CA16056. Publications should cite the Core grant in the acknowledgment section, if publications use data generated by the shared resource. Two copies of the publication, acknowledging the Core grant, should be submitted to the facility at Elm & Carlton Streets, Buffalo NY,  14263.

PDF icon BMPK Progress Report 201678.63 KB